Personalis (PSNL) Gains from Investment Securities (2018 - 2019)
Personalis (PSNL) posted quarterly Gains from Investment Securities of $1.3 million for Q2 2019, up 847.01% quarter-over-quarter from $134000.0 in Q1 2019.
Personalis (PSNL) Gains from Investment Securities (2018 - 2019) Analysis & Trends
Personalis' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2019.
- In Q2 2019, Gains from Investment Securities changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2019 stood at $1.4 million (changed N/A YoY), while the FY2019 annual figure was $1.4 million, up 258.82% from the prior year.
- Gains from Investment Securities for Q2 2019 stood at $1.3 million, up from $134000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.3 million in Q2 2019, with the low at $134000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Personalis | 1.40 Bn | 1.17 Bn | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 1.27 Mn |
| Jun 30, 2019 | 1.27 Mn |
| Mar 31, 2019 | 134,000.00 |
| Mar 31, 2019 | 134,000.00 |
| Dec 31, 2018 | 225,000.00 |
| Dec 31, 2018 | 225,000.00 |